Zikani Therapeutics, Inc. — Form D

Zikani Therapeutics, Inc. of Watertown, MA, a company, filed a Form D exempt-offering notice with the SEC on 2015-02-25. The offering totals $22.3M, of which $8.2M was reported sold. Industry: Pharmaceuticals.

Offering

Issuer

Officers, directors & promoters (23)

NameRoleLocation
ANDREW MYERSDirectorSAN FRANCISCO, CA
Mary SzelaDirectorWestminster, CO
Raj ParekhDirectorWaltham, MA
Lawrence MillerDirectorAston, PA
Lawrence MillerExecutive OfficerAston, PA
Sumit AggarwalDirectorWatertown, MA
Sumit AggarwalExecutive OfficerWatertown, MA
Christopher A ViehbacherDirectorWatertown, MA
Raj B Parekh, Ph.D.DirectorWatertown, MA
Anja HarmeierDirectorBoston, MA
Christopher ViehbacherDirectorCambridge, MA
HENRY SKINNERDirectorSAN DIEGO, CA
Vikas GoyalDirectorBoston, MA
Markus GoebelDirectorSunnyvale, CA
Joseph ZakrzewskiDirectorWatertown, MA
Edward MascioliExecutive OfficerWatertown, MA
Andrew G LittlehaleExecutive OfficerWATERTOWN, MA
Henry G SkinnerDirectorWATERTOWN, MA
Monique G SciersingDirectorWATERTOWN, MA
Raj G ParekhDirectorWATERTOWN, MA
Andrew G MyersDirectorWATERTOWN, MA
Vikas G GoyalDirectorWATERTOWN, MA
Fereydoun G FirouzDirectorWATERTOWN, MA

Other filings by this issuer (3)

FiledFormOfferingSold
2020-04-16D$7.5M$7.5M
2018-03-13D$20.0M$12.0M
2016-04-29D/A$27.8M$12.2M

More